Anti-ALK Antibodies in Patients with ALK-Positive Malignancies Not Expressing NPM-ALK

被引：9

作者：

Damm-Welk, Christine ^{[1
,2
]}

Siddiqi, Faraz ^{[3
]}

Fischer, Matthias ^{[4
,5
,6
]}

Hero, Barbara ^{[4
]}

Narayanan, Vignesh ^{[7
]}

Camidge, David Ross ^{[7
]}

Harris, Michael ^{[3
]}

Burke, Amos ^{[8
]}

Lehrnbecher, Thomas ^{[9
]}

Pulford, Karen ^{[10
]}

Oschlies, Ilske ^{[11
]}

Siebert, Reiner ^{[12
,13
]}

Turner, Suzanne ^{[3
]}

Woessmann, Wilhelm ^{[1
,2
]}

机构：

[1] Univ Giessen, NHL BFM Study Ctr, Giessen, Germany

[2] Univ Giessen, Dept Paediat Haematol & Oncol, Feulgenstr 12, D-35392 Giessen, Germany

[3] Univ Cambridge, Dept Pathol, Cambridge, England

[4] Univ Cologne, Dept Paediat Haematol & Oncol, Cologne, Germany

[5] Univ Cologne, Fac Med, Ctr Mol Med Cologne, Cologne, Germany

[6] Max Planck Inst Metab Res, Cologne, Germany

[7] Univ Colorado, Ctr Canc, Aurora, CO USA

[8] Addenbrookes Hosp, Dept Paediat Oncol, Cambridge, England

[9] Goethe Univ Frankfurt, Dept Paediat Haematol & Oncol, Frankfurt, Germany

[10] Univ Oxford, Nuffield Div Clin Lab Sci, Oxford, England

[11] Univ Kiel, Dept Pathol, Kiel, Germany

[12] Univ Kiel, Inst Human Genet, Campus Kiel, Kiel, Germany

[13] Univ Hosp Schleswig Holstein, Campus Kiel, Kiel, Germany

来源：

JOURNAL OF CANCER | 2016年 / 7卷 / 11期

基金：

英国惠康基金;

关键词：

ALK-antibody titre; NSCLC; neuroblastoma; lymphoma; ANAPLASTIC LYMPHOMA KINASE; LARGE-CELL LYMPHOMA; LUNG-CANCER; TYROSINE KINASE; NEUROBLASTOMA; GENE; FEATURES; DISEASE; ALCL; IDENTIFICATION;

D O I：

10.7150/jca.15238

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Patients with Nucleophosmin (NPM)- Anaplastic Lymphoma Kinase (ALK) fusion positive Anaplastic Large Cell Lymphoma produce autoantibodies against ALK indicative of an immune response against epitopes of the chimeric fusion protein. We asked whether ALK-expression in other malignancies induces specific antibodies. Antibodies against ALK were detected in sera of one of 50 analysed ALK-expressing neuroblastoma patients, 13 of 21 ALK positive non-small cell lung carcinoma (NSCLC) patients, 13 of 22 ALK translocation-positive, but NPM-ALK-negative lymphoma patients and one of one ALK-positive rhabdomyosarcoma patient, but not in 20 healthy adults. These data suggest that boosting a pre-existent anti-ALK immune response may be more feasible for patients with ALK-positive NSCLC, lymphomas and rhabdomyosarcomas than for tumours expressing wild-type ALK.

引用

页码：1383 / 1387

页数：5

共 50 条

[21] Conditional NPM-ALK and TPM3-ALK transgenic mice
Giuriato, S.
Felsher D, W.
Saati, At, V
Demur, C.
Ragab, A.
Kruczynski, A.
Schiff, C.
Delsol, G.
Meggetto, F.
BULLETIN DU CANCER, 2008, 95 : S28 - S28
[22] Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma
Iijima-Yamashita, Yuka
Mori, Tetsuya
Nakazawa, Atsuko
Fukano, Reiji
Takimoto, Tetsuya
Tsurusawa, Masahito
Kobayashi, Ryoji
Horibe, Keizo
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (02) : 244 - 250
[23] ALK Translocation in ALK-Positive Mesenchymal Tumors
Jung, Minsun
Moon, Kyung Chul
Bae, Jeongmo
Kim, Tae Min
Kim, Miso
Jeon, Yoon Kyung
Lee, Cheol
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (12) : 1460 - 1470
[24] Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma
Yuka Iijima-Yamashita
Tetsuya Mori
Atsuko Nakazawa
Reiji Fukano
Tetsuya Takimoto
Masahito Tsurusawa
Ryoji Kobayashi
Keizo Horibe
International Journal of Hematology, 2018, 107 : 244 - 250
[25] Anti-ALK autoantibodies in patients with ALK positive non-small cell lung cancer (NSCLC)
Parisi, C.
Benitez, J. C.
Lecourt, H.
Dall'Olio, F. G.
Aldea, M.
Blanc-Durand, F.
Verge, V.
Quivoron, C.
Naltet, C.
Abdayem, P.
Lavaud, P.
Ghigna, M. R.
Loriot, Y.
De Botton, S.
Planchard, D.
Barlesi, F.
Soria, J-C.
Ribrag, V.
Friboulet, L.
Besse, B.
ANNALS OF ONCOLOGY, 2021, 32 : S956 - S957
[26] STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma
Wu, Chengsheng
Molavi, Ommoleila
Zhang, Haifeng
Gupta, Nidhi
Alshareef, Abdulraheem
Bone, Kathleen M.
Gopal, Keshav
Wu, Fang
Lewis, Jamie T.
Douglas, Donna N.
Kneteman, Norman M.
Lai, Raymond
BLOOD, 2015, 126 (03) : 336 - 345
[27] Sonic hedgehog signaling is activated by NPM/ALK in ALK-positive anaplastic large cell lymphomas
Cho-Vega, J. H.
Singh, R. R.
Luthra, R.
Ma, S.
Davuluri, Y.
Drakos, E.
Rassidaki, G. Z.
Medeiros, L. J.
Vega, F.
LABORATORY INVESTIGATION, 2008, 88 : 249A - 249A
[28] Sonic hedgehog signaling is activated by NPM/ALK in ALK-positive anaplastic large cell lymphomas
Cho-Vega, J. H.
Singh, R. R.
Luthra, R.
Ma, S.
Davuluri, Y.
Drakos, E.
Rassidakis, G. Z.
Mederios, L. J.
Vega, F.
MODERN PATHOLOGY, 2008, 21 : 249A - 249A
[29] Nuclear Interaction Partner of ALK (NIPA) is involved in NPM-ALK driven lymphomagensis
Lippert, L. J.
Shlyakhto, V
Kreutmair, S.
Klingeberg, C.
Albers, C.
Miething, C.
Duyster, J.
Illert, A. L.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 238 - 239
[30] B and CTL responses to the ALK protein in patients with ALK-positive ALCL
Ait-Taharl, K
Cerundolo, V
Banham, AH
Hatton, C
Blanchard, T
Kusec, R
Becker, M
Smith, GL
Pulford, K
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (03) : 688 - 695

← 1 2 3 4 5 →